Cytokinetics, Inc. (CYTK)
75.18
-0.67
(-0.88%)
USD |
NASDAQ |
May 18, 16:00
76.19
+1.01
(+1.34%)
After-Hours: 05:58
Cytokinetics Research and Development Expense (Quarterly) : 92.15M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 2.238B |
| Regeneron Pharmaceuticals, Inc. | 1.420B |
| Sarepta Therapeutics, Inc. | 153.96M |
| Moderna, Inc. | 590.00M |
| Revolution Medicines, Inc. | 341.62M |